Related Experiment Videos
Cognition in relapsing-remitting multiple sclerosis: a multichannel event-related potential (P300) study
N I Triantafyllou1, K Voumvourakis, I Zalonis
1Neurological Clinic, Athens University Medical School, Eginition Hospital, Greece.
Acta Neurologica Scandinavica
|January 1, 1992
Summary
Auditory event-related potentials (AERP) show prolonged latencies and low amplitudes in multiple sclerosis (MS) patients. These auditory processing changes correlate with MS disability but not disease duration, suggesting potential cognitive impacts.
Area of Science:
- Neuroscience
- Clinical Neurology
- Auditory Neuroscience
Background:
- Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
- Cognitive dysfunction is a common but often underdiagnosed symptom in MS patients.
- Auditory event-related potentials (AERP) offer a non-invasive method to assess central auditory pathway integrity.
Purpose of the Study:
- To investigate auditory processing in relapsing-remitting multiple sclerosis (RRMS) using AERP.
- To determine if AERP alterations correlate with clinical disability or disease duration in MS.
- To explore potential cognitive implications of observed AERP changes.
Main Methods:
- Elicited AERP in 47 RRMS patients and 24 age-matched healthy controls.
- Measured N2 and P3 latencies and P3 amplitude.
- Correlated AERP parameters with Kurtzke Expanded Disability Status Scale (EDSS) scores and disease duration.
Main Results:
- MS patients exhibited significantly prolonged N2 and P3 latencies compared to controls.
- A significantly lower P3 amplitude was observed in MS patients.
- N2 and P3 alterations were associated with higher EDSS scores, indicating greater disability.
- No significant relationship was found between AERP changes and disease duration.
Conclusions:
- AERP abnormalities, specifically prolonged latencies and reduced P3 amplitude, are present in RRMS patients.
- These auditory processing deficits are linked to the degree of neurological disability in MS.
- The findings suggest potential subclinical cognitive impairment in MS patients, warranting further investigation.